PD-1/PD-L1-IN-28

PD-1/PD-L1-IN-28 is a small molecule immune checkpoint inhibitor with an IC50 of 0.744 μM, effectively blocking the PD-1/PD-L1 interaction. It is a valuable research tool for investigating cancer immunotherapy mechanisms in both in vitro binding assays and in vivo tumor model studies.